Clinical Study Of Raal churna (resin of shorea robusta) And Nagkeshara(Mesua ferrea Linn.) Churna In the treatment Of White vaginal Discharge(Leucorrhoea) in females.

Phase 2/3

Not yet recruiting

• Conditions: Inflammatory diseases of female pelvic organs. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH,

• Registration Number: CTRI/2022/12/047900
• Lead Sponsor: Government Dhanvantari Ayurvedic College And Hospital Ujjain

Brief Summary

This is randomized interventional a Pharmaco-therapeutic Study Of *Shala (Shorea robusta Gaertn.f) Niryasa and Nagkeshara (Mesua Ferrea Linn.) Churna in Management Of Sweta Pradara- A Comparative Study  Total 60 Patients will be enrolled in the present study. Selected Patients will be divided into two groups on the basis of computer generated randomization.*

*Group A 30 Patients will be treated with Shala Niryasa Churna 2 gms along with lukewarm water orally before meals TDS for 6 weeks*

*Group B 30 Patients will be treated with Nagkeshara Churna 3 gms along with Takra orally before meals BD for 6 weeks*

*Follow up will be taken on 15th day then 30 th day and lastly on 45th day*

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-02-12
• Study Start: 2022-08-12

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

1 Married Female Patients Of Age 18 to 55 Years 2 Patients Presenting With Complaints Of White Discharge Per Vginum 3 Patients Willing To Register And Sign The Consent Form.

Exclusion Criteria

1 Unmarried female 2 Patient having any type of malignancy 3 Patient having positive VDRL HIV HbsAg Tuberculosis Pelvic inflammatory diseases and STDs 4 Pregnant women and Lactating Mothers 5 Patient having any Chronic systemic Illness 6 Age below 18 year and above 55 year.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in the Signs and Symptoms of white discharge including Amount of discharge at the time of baseline and at the end of the treatment (After 6 weeks)	Change in the Signs and Symptoms of white discharge including Amount of discharge at the time of baseline and at the end of the treatment (After 6 weeks)

Secondary Outcome Measures

Name	Time	Method
Assessment of change in the clinical parameters on 15th day	30th and 45th day

Trial Locations

Locations (1)

Government Dhanvantari Ayurvedic College And Hospital Ujjain; 🇮🇳 Ujjain, MADHYA PRADESH, India

Government Dhanvantari Ayurvedic College And Hospital Ujjain

🇮🇳Ujjain, MADHYA PRADESH, India

Dr Shiromani Mishra

Principal investigator

9893158853

shiromishra@gmail.com